Frontiers in Cell and Developmental Biology
•
2023
Volume 11
Pages 1122334
Troxerutin-Mediated Complement Pathway Inhibition is a Disease-Modifying Treatment for Inflammatory Arthritis
Sahu D., Chen L., Vasquez E.
5.5
Impact Factor
Abstract
This study integrated computational pathway analysis with in vivo experimental confirmation to evaluate troxerutin as a disease-modifying treatment for inflammatory arthritis.
How to cite this article
Sahu D., Chen L., Vasquez E. (2023). Troxerutin-Mediated Complement Pathway Inhibition is a Disease-Modifying Treatment for Inflammatory Arthritis. Frontiers in Cell and Developmental Biology, 11, 1122334. https://doi.org/10.3389/fcell.2023.1122334
Related Publications
-
Troxerutin-Mediated Complement Pathway Inhibition is a Disease-Modifying Treatme...Frontiers in Cell and Developmental Biology (2023)
-
An Insight into the Therapeutic Applications of Coumarin Compounds and Their Mec...European Journal of Pharmaceutical Sciences (Elsevier) (2023)
-
An Outbreak of Oxidative Stress in Pathogenesis of Alzheimer's DiseaseSmart Nanodevices for Point-of-Care Applications (Book Chapter) (2023)